Late post-transplant anemia in adult renal transplant recipients. An under-recognized problem?

被引:120
作者
Yorgin, PD [3 ]
Scandling, JD
Belson, A
Sanchez, J
Alexander, SR
Andreoni, KA
机构
[1] Stanford Univ, Dept Med, Sect Transplant Nephrol, Palo Alto, CA 94304 USA
[2] Univ N Carolina, Dept Transplant Surg, Chapel Hill, NC 27514 USA
[3] Stanford Univ, Lucile Salter Packard Childrens Hosp, Sect Pediat Nephrol, Stanford, CA 94305 USA
关键词
calculated creatinine clearance; corticosteroids; erythropoietin; ethnicity; gender; hematocrit; iron deficiency; mycophenolate mofetil;
D O I
10.1034/j.1600-6143.2002.20506.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Post-transplant anemia (PTA), a frequent complication during the first 3-6 months after transplant, is thought to be uncommon during the late post-transplant period. A study population of adults (> 18 years) transplanted during 1995 at Stanford University (n = 88) and University of North Carolina (n = 40) was selected. Data-collection points were 0, 1, 2, 3, 4 and 5 years post transplant. Anemia was defined as a hematocrit <33 volume percentage. Thirty percent of patients were anemic at some time during the post-transplant period. The prevalence of PTA increased over time; by 5 years post transplant, 26% of the patients were anemic. Anemia occurred in 62.5% of patients converted from azathioprine to mycophenolate mofetil. A multivariate logistic regression model demonstrated a correlation between anemia and serum total CO2 (p = 0.002), BUN (p = 0.04), and creatinine (p = 0.045) at I year post transplant. At 5 years post transplant, only serum total CO2 (P =0.0004) correlated with anemia. Thus, diminished renal excretory function and metabolic acidosis appear to be the most important correlates of late PTA. These findings should be interpreted In view of the fact that the newer immunosuppressive agents may have an even more profound effect on anemia and its recovery after transplantation.
引用
收藏
页码:429 / 435
页数:7
相关论文
共 36 条
[1]   BODY-FLUID SPACES AND BLOOD-PRESSURE IN HEMODIALYSIS-PATIENTS DURING AMELIORATION OF ANEMIA WITH ERYTHROPOIETIN [J].
ABRAHAM, PA ;
OPSAHL, JA ;
KESHAVIAH, PR ;
COLLINS, AJ ;
WHALEN, JJ ;
ASINGER, RW ;
MCLAIN, LA ;
HANSON, G ;
DAVIS, MG ;
HALSTENSON, CE .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1990, 16 (05) :438-446
[2]  
[Anonymous], 1997, Am J Kidney Dis, V30, pS192
[3]   Reproducible erythroid aplasia caused by mycophenolate mofetil [J].
Arbeiter, K ;
Greenbaum, L ;
Balzar, E ;
Müller, T ;
Hofmeister, F ;
Bidmon, B ;
Aufricht, C .
PEDIATRIC NEPHROLOGY, 2000, 14 (03) :195-197
[4]   DYNAMICS OF ERYTHROPOIESIS FOLLOWING RENAL-TRANSPLANTATION [J].
BESARAB, A ;
CARO, J ;
JARRELL, BE ;
FRANCOS, G ;
ERSLEV, AJ .
KIDNEY INTERNATIONAL, 1987, 32 (04) :526-536
[5]  
Beshara S, 1997, EUR J HAEMATOL, V58, P167
[6]  
BROWN JH, 1989, NEPHROL DIAL TRANSPL, V4, P1076
[7]   PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[8]   AZATHIOPRINE-ASSOCIATED PURE RED-CELL APLASIA [J].
CREEMERS, GJ ;
VANBOVEN, WPL ;
LOWENBERG, B ;
VANDERHEUL, C .
JOURNAL OF INTERNAL MEDICINE, 1993, 233 (01) :85-87
[9]   Normal ranges for packed cell volume and hemoglobin concentration in adults: relevance to 'apparent polycythemia' [J].
Fairbanks, VF ;
Tefferi, A .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2000, 65 (05) :285-296
[10]   SERUM ERYTHROPOIETIN LEVELS IN THE IMMEDIATE KIDNEY-POSTTRANSPLANT PERIOD [J].
GOCH, J ;
BIRGEGARD, G ;
WIKSTROM, B ;
TUFVESON, G ;
DANIELSON, BG .
NEPHRON, 1992, 60 (01) :30-34